Trial intelligence / Profile preview

Baclofen in Alcoholic Liver Disease

NCT01711125Phase 3Completed

Sponsor
South Western Sydney Local Health District
Start
Mar 2013
Primary completion
Jun 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of baclofen in alcohol dependence, sponsored by South Western Sydney Local Health District. Started Mar 2013; status: completed.

02

Drugs

baclofen
03

Conditions

alcohol dependence

Beyond the preview

Go deeper on NCT01711125.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01711125.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call